Headache is one of the most common presenting symptoms in primary care and represents a high proportion of patients referred to a neurology specialist. Poorly managed acute headaches can lead to a chronicity of symptoms, and poorly managed chronic headaches can lead to depression, lost productivity, and reduced quality of life. Nurse Practitioners need to know how to differentiate primary versus secondary headaches, particularly when s secondary headache can be the result of a serious life limiting condition. Thankfully the vast majority of headaches presenting in primary care are of the “primary” variety and knowledge of management with pharmacotherapies and non-pharmacotherapies is vital to a primary care practice. This lecture will focus on the most up to date pharmacotherapies available for primary headache disorders. | 1.50 credits (1.25 Pharmacology) | $40

This presentation focuses on the practical application of pharmacotherapy for depression in primary care. How to differentiate among SSRIs, and what to do when SSRIs are inadequate or contraindicated. Decisioning pharmacotherapy in the primary care setting and determining when it is appropriate to refer provides a foundation for best practices for the primary care provider. | 1.50 credits (1.50 Pharmacology) | $45

Influenza and COVID-19 are both respiratory illnesses that can cause serious complications, especially in high-risk populations. Nurse practitioners play a key role in the diagnosis and treatment of influenza and COVID-19 infections. This presentation will evaluate the different types of antiviral medications and their pharmacologic features. Patient populations who are most likely to benefit from antiviral therapy will be reviewed. This presentation will examine the most up to date evidence related to efficacy and safety of antivirals for influenza and COVID-19, and provide an approach to the appropriate use of these medications in clinical practice. | 1.50 credits (1.50 Pharmacology) | $40

In 2019, the Infectious Disease Society of America and American Thoracic Society published updated recommendations for managing patients with community-acquired pneumonia (CAP) generating new considerations for inpatient and outpatient practitioners. This presentation will assess emerging literature influencing the optimal pharmacologic management of CAP such as, changing etiologic trends, patient-specific factors, outcomes evidence, and risk factors for adverse drug reactions. | 1.50 credits (1.50 Pharmacology) | $40

Given the limited access to mental health specialists, primary care practitioners must often diagnose, initiate treatment, and chronically manage different anxiety disorders. This presentation utilizes evidence-based medicine and case studies to discuss the underlying pathophysiology of anxiety and the different options of pharmaceuticals in the treatment of anxiety. | 1.50 credits (1.50 Pharmacology) | $45

This lecture will review the general pathophysiology and epidemiology of various liver diseases with a greater focus on liver cirrhosis and associated sequelae including how to approach management of these complications. We will also review pharmacology options in the management of other common chronic liver diseases. | 1.50 credits (1.50 Pharmacology) | $40

This lecture will review the general pathophysiology and epidemiology of C.diff and H.pylori and outline at risk populations as well as appropriate diagnostic testing and current management strategies. | 1.50 credits (1.50 Pharmacology) | $40

This presentation will review pharmacological management of the common types of hypo and hyperthyroidism along with an overview of thyroid hormones and their effect on the hypothalamic-pituitary-thyroid axis. | 1.50credits (1.50 Pharmacology) | $40

Update on treatment of migraines utilizing case studies. | 1.50 credits (1.50 Pharmacology) | $40

The management of type 2 diabetes involves a multifaceted approach to control blood sugar levels and mitigate complications. Lifestyle modifications are crucial, including a balanced diet, regular exercise, and weight management. Medications like metformin, has been the mainstay of type 2 diabetes management. Over the past several years, guidelines have shifted away from a glucose centric focus to prioritizing cardio-renal management. Therapeutic inertia has created a situation where our type 2 diabetic patients are increasingly not reaching their A1C goals and under-prescribed appropriate goal directed medications. | 1.5 credits (1.50 Pharmacology) | $40